Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth (original) (raw)
Miller JR . The Wnts. Genomic Biol 2001; 3: 1–8. Google Scholar
Karim R, Tse Q, Putti T, Scolyer R, Lee S . The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004; 36: 120–128. ArticleCASPubMed Google Scholar
Mikels AJ, Nusse R . Wnts as ligands: processing, secretion and reception. Oncogene 2006; 25: 7461–7468. ArticleCASPubMed Google Scholar
van Es JH, Barker N, Clevers H . You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 2003; 13: 28–33. ArticleCASPubMed Google Scholar
Mikels AJ, Nusse R . Purified Wnt5a protein: activates or inhibits β-catenin-TCF signaling depending on receptor context. PLOS Biol 2006; 4: e115. ArticlePubMedPubMed Central Google Scholar
Giles RH, van Es JH, Clevers H . Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003; 1653: 1–24. CASPubMed Google Scholar
Schweizer L, Varmus H . Wnt/Wingless signaling through β-catenin requires the function of both LRP/Arrow and frizzled classes of receptors. BMC Cell Biol 2003; 4: 4. ArticlePubMedPubMed Central Google Scholar
Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M et al. Target genes of β-catenin-T-cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999; 96: 1603–1608. ArticleCASPubMedPubMed Central Google Scholar
Jiang RC, Pu PY, Shen CH, Yu SZ, Jiao BH, Kang CS . Preliminary study on cancer-related gene expression profiles in 63 cases of gliomas by cDNA array. Chin J Neurosurg 2004; 20: 18–21. Google Scholar
Jiang RC, Pu PY, Shen CH, Jiao BH, Yu SZ, Kang CS et al. Preliminary study on the gene expression profiles of ependymomas with cDNA array. Chin J Surg 2003; 41: 770–772. PubMed Google Scholar
Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006; 66: 10439–10448. ArticleCASPubMed Google Scholar
Pu P, Kang C, Zhang Z, Liu X, Jiang H . Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo. Tech Cancer Res Treat 2006; 5: 271–280. ArticleCAS Google Scholar
Kang CS, Zhang ZY, Jia ZF, Wang GX, Qiu MZ, Zhou HX et al. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 2006; 13: 530–538. ArticleCASPubMed Google Scholar
Howng SL, Wu CH, Cheng TS, Sy WD, Lin PC, Wang C et al. Differential expression of Wnt genes, β-catenin and E-cadherin in human brain tumors. Cancer Lett 2002; 183: 95–101. ArticleCASPubMed Google Scholar
Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J et al. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002; 21: 6598–6605. ArticleCASPubMed Google Scholar
Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY et al. Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer 2005; 117: 326–332. ArticleCASPubMed Google Scholar
Pham K, Milovanovic T, Barr RJ, Truong T, Holcombe RF . Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features. J Clin Pathol Mol Pathol 2003; 56: 280–285. ArticleCAS Google Scholar
Katoh M . Frequent upregulation of Wnt2 in primary gastric cancer and colorectal cancer. Int J Oncol 2001; 19: 1003–1007. CASPubMed Google Scholar
Katoh M . Wnt2 and human gastrointestinal cancer. Int J Mol Med 2003; 12: 811–816. CASPubMed Google Scholar
Utsuki S, Sato Y, Oka H, Tsuchiya B, Suzuki S, Fujii K . Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol 2002; 57: 187–192. ArticlePubMed Google Scholar
Moon RT, Kohn AD, De Ferrari GV, Kaykas A . Wnt and β-catenin signalling: diseases and therapies. Nat Rev Genet 2004; 5: 689–699. Article Google Scholar
Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C et al. β-Catenin mutation is a frequent cause of Wnt pathway activation on gastric cancer. Cancer Res 2002; 62: 3503–3506. CASPubMed Google Scholar
de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95: 8847–8851. ArticleCASPubMed Google Scholar
Gilbertson RJ . Medulloblastoma: signaling a change in treatment. Lancet Oncol 2004; 5: 209–218. ArticlePubMed Google Scholar
Koch A, Waha A, Tonn JC, Sorensen N, Berthold F, Wolter M et al. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 2001; 93: 445–449. ArticleCASPubMed Google Scholar
Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE et al. Beta-catenin status predicts a favorable outcome in childhood medulloblastoma. J Clin Oncol 2005; 23: 7951–7957. ArticleCASPubMed Google Scholar
Yokota N, Nishizawa S, Ohta S, Date H, Sugimura H, Namba H et al. Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 2002; 101: 198–201. ArticleCASPubMed Google Scholar
Bourguignon LY, Peyrollier K, Gilad E, Brightman A . Hyaluronan-CD44 interaction with neural Wiskott–Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem 2007; 282: 1265–1280. ArticleCASPubMed Google Scholar
Ventura AC, Sepulchre JA, Merajver SD . A hidden feedback in signaling cascades is revealed. PLoS Comput Biol 2007; 4: e1000041. Article Google Scholar
You Z, Saims D, Chen S, Zhang Z, Guttridge DC, Guan KL et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 2002; 157: 429–440. ArticleCASPubMedPubMed Central Google Scholar
Kolligs FT, Hu G, Dang CV, Fearon ER . Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-Myc expression. Mol Cell Biol 1999; 19: 5696–5706. ArticleCASPubMedPubMed Central Google Scholar
Takayama S, Rogatsky J, Schwarcz LE, Darimont BD . The glucocorticoid receptor represses cyclin D1 by targeting the TCF/beta-catenin complex. J Biol Chem 2006; 281: 17856–17863. ArticleCASPubMed Google Scholar
Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S et al. Epidermal growth factor receptor: a novel target of the Wnt/beta catenin pathway in liver. Gastroenterology 2005; 129: 285–302. ArticleCASPubMed Google Scholar
Musgrove EA . Wnt signaling via the epidermal growth factor receptor: a role in breast cancer? Breast Cancer Res 2004; 6: 65–68. ArticleCASPubMed Google Scholar
Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I et al. Activation of Notch 1 signaling is required for β-catenin-mediated human primary melanoma progression. J Clin Invest 2005; 115: 3166–3176. ArticleCASPubMedPubMed Central Google Scholar
Maeda O, Kondo M, Fujita T, Usami N, Fukui T, Shimokata K et al. Enhancement of GLI1-transcription activity by β-catenin in human cancer cells. Oncol Rep 2006; 16: 91–96. CASPubMed Google Scholar
Huang M, Wang Y, Sun D, Zhu H, Yin Y, Zhang W et al. Identification of genes regulated by Wnt/β-catenin and involved in apoptosis via microarray analysis. BMC Cancer 2006; 6: 221–231. ArticlePubMedPubMed Central Google Scholar
Sangkhathat S, Kusafuka T, Miao J, Yoneda A, Nara K, Yamamoto S et al. In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors. Int J Oncol 2006; 28: 715–722. CASPubMed Google Scholar
Herbst A, Kolligs FT . Wnt signaling as a therapeutic target for cancer. Methods Mol Biol 2007; 361: 63–91. CASPubMed Google Scholar